Protalix BioTherapeutics
PLX
#8199
Rank
A$0.30 B
Marketcap
$3.96
Share price
-8.08%
Change (1 day)
109.56%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): $0.15

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is $0.17. In 2022 the company made an earnings per share (EPS) of -$0.50 an increase over its 2021 EPS that were of -$1.03.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.15-130.87%
2022-$0.50-51.61%
2021-$1.03342.86%
2020-$0.23-88.71%
2019-$2.05-34.74%
2018-$3.14-70.92%
2017-$10.822153.35%
2016-$0.48-146.77%
2015$1.03-287.88%
2014-$0.5510%
2013-$0.50130.77%
2012-$0.22-56.67%
2011-$0.50-46.43%
2010-$0.9336.59%
2009-$0.6832.26%
2008-$0.51-93.4%
2007-$7.781298.53%
2006-$0.56-96.59%
2005-$16.3219.32%
2004-$13.681552.65%
2003-$0.83-0%
2002-$0.83-50%
2001-$1.66233.33%
2000-$0.50-84.21%
1999-$3.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.06-740.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.24 1,860.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.08 1,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.31-2,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel